Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epigenetic silencing of the ANKRD26 gene correlates to the pro-inflammatory profile and increased cardio-metabolic risk factors in human obesity.
Desiderio A, Longo M, Parrillo L, Campitelli M, Cacace G, de Simone S, Spinelli R, Zatterale F, Cabaro S, Dolce P, Formisano P, Milone M, Miele C, Beguinot F, Raciti GA. Desiderio A, et al. Among authors: campitelli m. Clin Epigenetics. 2019 Dec 4;11(1):181. doi: 10.1186/s13148-019-0768-0. Clin Epigenetics. 2019. PMID: 31801613 Free PMC article.
Real-world outcomes of PARP inhibitor maintenance in advanced ovarian cancer: a focus on disease patterns and treatment modalities at recurrence.
Loverro M, Marchetti C, Salutari V, Giannarelli D, Vertechy L, Capomacchia FM, Caricato C, Campitelli M, Panico C, Avesani G, Cocciolillo F, Rosati A, Scambia G, Fagotti A. Loverro M, et al. Among authors: campitelli m. ESMO Open. 2025 Jan 17;10(2):104119. doi: 10.1016/j.esmoop.2024.104119. Online ahead of print. ESMO Open. 2025. PMID: 39826478 Free article.
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups.
Macchia G, Pezzulla D, Russo D, Campitelli M, Lucci S, Fanelli M, Deodato F, Fagotti A, Gambacorta MA, Savarese A, Pignata S, Aristei C, Ferrandina G. Macchia G, et al. Among authors: campitelli m. Anticancer Drugs. 2025 Jan 8. doi: 10.1097/CAD.0000000000001684. Online ahead of print. Anticancer Drugs. 2025. PMID: 39784120
161 results